These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3070468)

  • 21. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 22. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
    Morales CP; Lee EL; Shay JW
    Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
    Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett's esophagus and adenocarcinoma of the gastrica cardia.
    Conio M; Cameron AJ
    Gastrointest Endosc; 2001 Dec; 54(6):799-801. PubMed ID: 11762326
    [No Abstract]   [Full Text] [Related]  

  • 25. Endoscopic resection of adenocarcinoma arising in a tongue of Barrett's esophagus.
    Harada M; Nagashima R; Takeda H; Takahashi T
    Gastrointest Endosc; 2000 Sep; 52(3):427-9. PubMed ID: 10968868
    [No Abstract]   [Full Text] [Related]  

  • 26. Surgical therapy for Barrett's esophagus with high-grade dysplasia and early esophageal carcinoma.
    Gilbert S; Jobe BA
    Surg Oncol Clin N Am; 2009 Jul; 18(3):523-31. PubMed ID: 19500741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Pro.
    Wani S; Choi W; Sharma P
    Endoscopy; 2007 Jul; 39(7):643-6. PubMed ID: 17611920
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus.
    Pohl H; Koch M; Khalifa A; Papanikolaou IS; Scheiner K; Wiedenmann B; Rösch T
    Endoscopy; 2007 Jun; 39(6):492-6. PubMed ID: 17554642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
    Stein HJ; von Rahden BH; Höfler H; Siewert JR
    Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Contra.
    Vieth M
    Endoscopy; 2007 Jul; 39(7):647-9. PubMed ID: 17611921
    [No Abstract]   [Full Text] [Related]  

  • 31. Barrett's esophagus: a model of human neoplastic progression.
    Neshat K; Sanchez CA; Galipeau PC; Cowan DS; Ramel S; Levine DS; Reid BJ
    Cold Spring Harb Symp Quant Biol; 1994; 59():577-83. PubMed ID: 7587115
    [No Abstract]   [Full Text] [Related]  

  • 32. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
    Cameron AJ; Carpenter HA
    Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenocarcinoma and Barrett's esophagus. An overrated risk?
    Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM
    Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endoscopic findings and treatment of a recurrent adenocarcinoma with a submucosal tumor-like appearance in short-segment Barrett's esophagus.
    Yagi K; Aruga Y; Nakamura A; Sekine A
    Endoscopy; 2006 Feb; 38(2):198. PubMed ID: 16479433
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term endoscopic surveillance of Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 2003 Sep; 98(9):1912-3. PubMed ID: 14499764
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of adenocarcinoma arising in Barrett's esophagus.
    DeMeester TR
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):290-301. PubMed ID: 9263348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Squamous reepithelialization after circumferential endoscopic mucosal resection of superficial carcinoma arising in Barrett's esophagus.
    Satodate H; Inoue H; Fukami N; Shiokawa A; Kudo SE
    Endoscopy; 2004 Oct; 36(10):909-12. PubMed ID: 15452789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Obesity Associated with Barrett's Esophagus and Esophageal Adenocarcinoma?
    Lynch KL
    Gastroenterol Clin North Am; 2016 Dec; 45(4):615-624. PubMed ID: 27837776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.